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Introduction
One of the most important predictors of clinical outcome 
after acute ischemic stroke is recanalization of the pri-
mary occlusion with subsequent reperfusion of the brain. 
The success rate is also influenced by the initial severity of 
the ischemic lesion, the pre-existing collaterals, the age of 
the patient, and the time between onset of symptoms and 
recanalization [1, 2]. The initial severity of stroke, rated 
by the National Institutes of Health Stroke Scale (NIHSS) 
score, is normally higher in big vessel occlusions (internal 
carotid-, middle cerebral-, and basilar arteries) [3]. At the 
same time, the rate of timely recanalization by intravenous 
thrombolysis is low in big vessel occlusions especially if the 
thrombus length exceeds 8 mm [4]. Conversely, mechanical 
thrombectomy can achieve recanalization rates up to 90 %, 
independent of the location and length of the thrombus [5], 
even in T-/L- or tandem occlusions of the internal carotid 
artery and its branches [6, 7].
In accordance with the specifications of this anniversary 
issue, this article brings into focus the evolution of instru-
ments and current techniques for revascularization of big 
vessel occlusions in acute stroke. Stroke registries and trials 
are the topic of another article in this issue, which will appre-
ciate also the recent groundbreaking ESCAPE; EXTEND, 
REVASCAT, THRACE and SWIFT-PRIME clinical trials, 
following the pioneering MRCLEAN study.
Intra-arterial Pharmacological Thrombolysis
With this technique that is of historical relevance because it 
was the first to be applied by neuroradiologists in Germany 
in the early 1980s, a microcatheter is navigated via a microw-
ire to the occlusion site and used to inject thrombolytic drugs 
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proximal to (PROlyse in Acute Cerebral Thrombembolism; 
PROACT) or directly into the thrombus (Middle cere-
bral artery Embolism Local fibrinolytic intervention Trial; 
MELT). Recanalization rates of 66 % [8], 74 % [9], or even 
higher [10] were achieved, with subsequent high rates of 
good clinical outcome: 41 % [8] and 49 % [9]. Local intra-
arterial thrombolysis therefore provides an inexpensive and 
relatively low-risk alternative when endovascular access is 
difficult, the site of occlusion is distal, or the calibers of the 
carotid or vertebral arteries are small. However, this treat-
ment has been vastly replaced by techniques aiming at the 
mechanical retrieval of clot.
Mechanical Treatment Approaches
Endovascular mechanical treatment approaches can be 
divided into five major groups according to their mecha-
nism of action:
 ● Thrombus disruption,
 ● Proximal thrombectomy, thrombaspiration
 ● Distal thrombectomy
 ● Stent recanalization
 ● Retrievable stents (stent retriever)
Thrombus Disruption
The goal of this technique is to increase the contact surface 
and penetration of the thrombolytic drug into the clot. Prob-
ing and fragmenting the thrombus with the microwire was 
the most frequently applied technique. Because the microw-
ire and the microcatheter never penetrate the thrombus itself, 
but pass the site of occlusion between the vessel wall and the 
thrombus [11], the risk of local spasms, dissections, and iat-
rogenic distal emboli is high. Nevertheless, when the tech-
nique was used as an adjunct to intra-arterial thrombolysis, 
successful recanalization of M1 occlusions was achieved in 
79 % of patients [10]. Another method of mechanical clot 
disruption is the use of percutaneous transluminal balloon 
angioplasty (PTA). Due to the risk of procedural complica-
tions and distal vessel occlusion due to emboli, this tech-
nique has not been accepted as a first-line treatment. More 
elaborated thrombus disruption devices apply ultrasound or 
laser technology (EKOS, Bothell, USA; EPAR, Endovasix, 
Belmont, USA), however the application was limited due to 
the restricted availability, costs, and complications such as 
iatrogenic distal emboli, intracranial hemorrhages, and dis-
sections caused by the rigid catheters.
Proximal Thrombectomy and Thrombaspiration
Manual suction thrombectomy is performed by advancing 
an aspiration catheter (usually 5–5.5-F) to the proximal sur-
face of the thrombus. Manual aspiration is applied using a 
syringe. The aspiration catheter is then retrieved under con-
stant negative pressure. Aspiration catheters must be flex-
ible enough to pass the tortuosity of the cranial vessels, such 
as the carotid siphon, braided enough not to collapse during 
aspiration, and big enough to catch and hold the thrombus.
Following the introduction and European Conformity 
(CE) certification of a dedicated 5-F aspiration catheter 
(VASCO-ASP, Balt), this approach was used in a multi-
modal treatment approach for proximal occlusions of ves-
sels such as the distal cervical internal carotid artery, the 
carotid terminus, or the basilar artery (Fig. 1). The drawback 
of this technique is the possible fragmentation of thrombotic 
material [12–13] due to elongation of the thrombus during 
aspiration, which remains a problem even since the intro-
duction of more flexible distal access catheters with larger 
bore. Thrombotic fragments obstruct the aspiration catheter 
and prohibit further aspiration, which requires retrieval and 
repositioning of the system.
The Penumbra system (Penumbra, Almeda, USA) is a 
modification of the manual proximal aspiration technique 
and consists of a dedicated reperfusion catheter connected 
to a pumping system that applies continuous suction. A 
microwire with an olive-shaped tip, the separator, is used 
to clean the tip of the reperfusion catheter of clot frag-
ments in order to avoid obstruction. Despite the relatively 
high recanalization rate, poor clinical outcomes prompted 
discussion of the impact of recanalization using mechani-
cal thrombectomy. Procedural-related iatrogenic emboli are 
one reason for the disappointing clinical outcome of this 
technique [14].
Both of these catheter systems may be used in combi-
nation with distal devices such as stent retrievers of com-
bine the effects or to facilitate reaccess in case of futile 
thrombectomy.
Distal Thrombectomy
Compared to proximal thrombectomy approaches, distal 
thrombectomy is technically more challenging because the 
occlusion site has to be passed with a microcatheter in order 
to deliver the device to the distal side of the thrombus. Sev-
eral distal thrombectomy devices have been introduced into 
clinical practice (e.g., Catch, BALT, Montmorency, France; 
Phenox pCR/CRC/Bonnet, Phenox GmbH, Bochum, Ger-
many; Merci device, Concentric Medical, Mountain View, 
USA).
In the Multi-MERCI trial [15], successful recanalization 
was achieved in 57.3 % of patients using the Merci retriever 
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Fig. 1 Thrombaspiration in an 18-year old patient with basilar oc-
clusion after cardiac OP. Start of the angio at 10:50, Dec 7th, 2000. 
Digital subtraction angiography (DSA) of the left vertebral artery at 
11:00 confirmed basilar artery occlusion in frontal (a) and lateral (b) 
projections. DSA of the right vertebral artery at 11:02 (c). DSA of the 
right common carotid artery at 11:03 (d). DSA of the left carotid artery 
at 11:04 (e). Control DSA of the left VA, 11:12, following aspiration of 
the thrombus confirmed TICI-3 recanalization (f). Thrombus fixed and 
removed at the top of the 5-F aspiration catheter (g)
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other recanalization methods have failed, and in the acute 
phase of stroke treatment in case of an underlying intracra-
nial stenosis (Fig. 2). Therefore, stenting is more frequently 
used in vertebrobasilar stroke in order to reduce the risk of 
reocclusion across a stenosis.
Self-expandable stents are preferentially used over bal-
loon-mounted stents and recanalization rates between 79 % 
and 92 % with moderate clinical outcome in 33–50 % [20] 
can be achieved.
Stent Retriever
The application of stent retrievers is comparable to that of 
intracranial stents. Initially, the occlusion site is passed with 
a microcatheter. Knowledge of the length and extension of 
the thrombus based on thrombus imaging, either using high 
resolution CT with thin slices, or T2* and SWI MR- tech-
niques, is helpful [4, 5] to unsheathe the device over the 
whole length of the thrombus. Following slow injection of 
1–2 ml contrast to confirm the position of the microcath-
eter in a sufficiently large artery distal to the thrombus, the 
stent retriever is deployed by retrieving the microcatheter 
alone and in 69.5 % using additional recanalization modali-
ties. However, favorable clinical outcome was achieved in 
only 36 %. A high rate of thrombus fragmentation and iatro-
genic emboli reported in experiments using Merci and other 
distal access devices [16] may serve as explanation. Never-
theless, the MERCI and Multi-MERCI trials promoted the 
introduction of the Merci device into widespread use for 
clinical studies, especially in the so-called unhappy triad 
[17–19].
Stent Recanalization
In comparison to thrombectomy devices, stenting allows 
fast and effective recanalization without repetitive pass-
ing of the occlusion site and retrieval attempts. However, 
this straight-forward concept has some disadvantages dur-
ing treatment of acute stroke. Permanent stent placement 
requires double platelet antiaggregation in order to prevent 
in-stent thrombosis and reocclusion, thrombus compression 
may lead to permanent side branch or perforator occlusion, 
and the rate of in-stent restenosis is high. However, stenting 
is clearly valuable in selective cases of rescue therapy when 
Fig. 2 Images from a 78-year-old female with progressive stroke. 
Computed tomography (CT) angiography from an external stroke unit 
showed mid-basilar occlusion (a), after which the patient was trans-
ferred via helicopter to our stroke center. Digital subtraction angiogra-
phy (DSA) of the left vertebral artery confirmed mid-basilar occlusion 
(b). Recanalization was achieved with percutaneous transluminal bal-
loon angioplasty (PTA) and implementation of a wingspan stent (c). 
At the 3-month follow-up flat panel 3-D rotation angiography with 
intravenous (i.v.) contrast showed normal flow in the basilar artery (d). 
After recovery to mRankin 0, the now 79-year-old patient agreed to in-
clusion of her photo (e), though she complained: “The helicopter flight 
was very interesting—however it was a little bit too cold—and I could 
not vocalize that and I was also unable to move and to pull the woolen 
blanket over me.” Retrospectively we became aware, that the patient 
had a locked-in syndrome, which we—fortunately—did not recognize, 
because it might have been a criteria for excluding treatment
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By adding the traction force of the stent retriever, which 
is applied over the whole length of the thrombus, and the 
suction force of the intermediate aspiration catheter, in addi-
tion to the negative pressure of the balloon-mounted guid-
ing catheter, the rate of recanalization can be increased, 
iatrogenic emboli diminished and the clinical outcome 
improved.
Discussion
Following the pioneering work of Mori, Zeumer, and 
Theron, other experts in the field of interventional neurora-
diology have evaluated the methods used in the PROACT 
and MELT clinical trials, and reported rates of recanaliza-
tion of about 70 % with good clinical outcome in more than 
40 % [8, 9]. We confirmed and improved these results, using 
this inexpensive and low-risk technique since 1992 in com-
bination with aspiration [10, 29] after CE certification of 
a dedicated 5-F aspiration catheter (VascoAsp, BALT). We 
changed to stent retriever technology after in vitro and pre-
clinical experiments confirmed that the occluding thrombus 
could be removed en bloc independently of its length [5].
Stent retriever technology is a definite step forward but 
albeit its methodologic simplicity not a “no brainer”. Clini-
cal outcome in studies using stent retriever thrombectomy 
without protection against iatrogenic emboli [27–29] were 
not convincing despite relatively high rates of revasculariza-
tion. Likewise, studies using mainly or exclusively throm-
bus fragmenting techniques and instruments have shown 
disappointing results [14, 15, 17–19].
Comparable to coiling of an aneurysm or embolization 
of an arteriovenous malformation (AVM), recanalization in 
acute stroke is an image-guided endovascular microneuro-
surgical operation, navigated by a biplane or 3D roadmap 
with a spatial resolution of 150 microns and a time resolu-
tion below 100 ms. For treatment of stroke, however, we 
must also navigate our microinstruments distally from the 
site of occlusion blindly, without a precise picture of our 
roadmap. New developments in the field of diagnostic neu-
roradiology will enable us to match the virtual anatomy of 
the vessels distal to the site of occlusion. This will be per-
formed in real time with biplane or 3-D roadmaps in the 
neuroangio-suite, using the late phases of CTA, MRA, or 
flat panel rotation angiography. In combination with throm-
bus imaging, we can guide our microinstruments safely and 
precisely beyond the site of occlusion, selectively in the 
branches of the MCA where the thrombus extends and that 
supply central regions of the hemisphere.
For planning the endovascular procedure, we consider 
it necessary to know the thrombus extent as well as each 
individual patient’s angioarchitecture from the aortic arch 
up to the distal branches of the large intracranial arteries. In 
and unsheathing the device covering the entire thrombus. 
The radial force of the stent retriever potentially generates a 
channel by compressing the thrombus and thereby partially 
restores blood flow to the distal territory in most cases, cre-
ating a channel for a temporary bypass. Recently, a new gen-
eration of stent retrievers has been introduced, addressing 
this potential benefit by a double stent-lumen design [21]. 
The immediate bypass effect has been confirmed using near-
infrared spectroscopy (NIRS) in patients with acute stroke 
(Fig. 3) after having tested this technique in other neurovas-
cular procedures [22]. The stent retriever is typically left in 
place for an embedding time of 2–5 min, especially when 
the immediate bypass works effectively, allowing engage-
ment of the thrombus within the stent struts.
To avoid iatrogenic emboli during mobilization and 
retraction of the thrombus, proximal and distal protection 
techniques have been developed that can be applied in 
combination.
During mobilization and retraction of the stent retriever, 
proximal balloon occlusion and flow reversal by additional 
aspiration at the guide catheter are recommended. The intro-
duction of this proximal protection was followed by a sig-
nificant improvement in the rate of recanalization as well as 
the clinical outcome [23–25], compared to the use of stent 
retrievers without mandatory use of protection devices [26–
28]. We presume, however, that the force of aspiration can 
only be transmitted to the intracranial arteries when the tip 
of the 8- or 9-F balloon-mounted guiding catheter is navi-
gated close to the petrous part of the ICA, because from this 
point the artery is embedded in the bone and cannot collapse 
as easily during aspiration. Thrombaspiration with the top 
of an 8-F guiding catheter at the skull base and proximal 
flow arrest enables aspiration of clot material extending to 
the carotid T and beyond [29].
The distal protection technique consists of a triaxial 
catheter access: an intermediate, large bore (at least 5-F) 
aspiration catheter is placed through the 8- or 9-F balloon-
mounted guiding catheter just in front of the occlusion and 
the microcatheter is advanced over the microwire through 
the site of occlusion. The intermediate catheter can be 
placed in the first step or as a second step [2].
We prefer to deliver the stent retriever during the first 
step to supply oxygen as quickly as possible to brain tis-
sue distal to the site of occlusion (Fig. 3). The next step is 
the removal of the microcatheter, which is sometimes chal-
lenging because stent retrievers with long exchange wires 
are not available. Injection of saline into the microcatheter 
with high pressure (using a 3 mm syringe) is a helpful tech-
nical trick to remove the microcatheter. The intermediate 
aspiration catheter is than loaded and navigated over the 
0.014 inch wire of the stent retriever in front of the site of 
occlusion.
304
1 3
T. Liebig et al.
Fig. 3 A 64-year-old female with acute tandem occlusion and a NIHSS 
of 19 (National Institutes of Health Stroke Scale). Digital subtraction 
angiography (DSA) of the left common carotid artery confirms internal 
carotid artery (ICA) occlusion (a). Dottering of the ICA occlusion with 
a 8-F catheter and passage of the thrombus in the middle cerebral ar-
tery (MCA) with the microcatheter via a 5-F distal access catheter (b). 
The probes of the near-infrared spectroscopy (NIRS) are well seen; 
they have been mounted in 6 min during local anesthesia without time 
delay for the treatment. Following deployment of the stent retriever, 
which created a capillary lumen in the left MCA (c), NIRS recordings 
(d) confirmed an immediate and dramatic increase of oxy-hemoglobin 
(red lines) and total cortical blood (green lines); desoxyhemoglobin 
(blue lines) remained stable or decreased, which may reflect the core 
and penumbra of the infarct. The thrombus extracted from the MCA 
by simultaneous retrieval of the stent and aspiration through the dis-
tal aspiration catheter (e). Percutaneous transluminal balloon angio-
plasty (PTA) of the ICA occlusion (f) resulted in stable flow, which 
was closely monitored by bedside Doppler-sonography. Two days after 
MCA-thrombectomy and ICA-PTA, 3T MRI (Magnetic resonance im-
aging) quality control confirmed, that ICA and MCA remained open 
(g: time of flight magnetic resonance angiography (TOF-MRA)), 
showed absence of iatrogenic distal emboli (h: whole brain suscepti-
bility weighted imaging (SWI)) and confirmed intact vessel walls (i: 
dark blood vessel wall). Three month later, the mRankin was 0 and the 
patient’s condition has remained stable for over 2 years
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daily practice, thrombus imaging guides us in the selection 
of the treatment approach. In patients with short thrombi 
measuring less than 8 mm in length, it may be warranted to 
start with intravenous thrombolysis and continue with endo-
vascular therapy as a second step [2], however without a 
waiting period or delay to wait for clinical improvement but 
to proceed to endovascular treatment immediately. Based on 
modern thrombus imaging [4, 5] of the length and extension 
of the occlusion of the cerebral artery, the stent retriever can 
be deployed over the whole length of the thrombus in order 
not to shear off distal thrombus parts during mobilization 
and retraction of the thrombus.
The risk of embolic complications is of particular concern 
in mechanical thrombectomy, as emboli can impair collat-
eral blood supply to the affected territory, accelerate penum-
bral tissue loss, and cause additional ischemic lesions. This 
is in accordance with a recent study demonstrating that the 
presence of multiple thrombi before initiation of thrombo-
lytic therapy predicted worse outcome [30].
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